Alluvi Retatrutide 40 mg refers to a research-grade formulation derived from Eli Lillys investigational compound Retatrutide (LY3437943).
It is a GLP-1, GIP and glucagon triple-agonist peptide being studied for its potential to regulate appetite, glucose levels, and overall energy expenditure.
Unlike approved weight-loss injections such as Wegovy (semaglutide) or Mounjaro (tirzepatide), Alluvi Retatrutide 20 mg remains in clinical trials.
Its mechanism activates three incretin pathways simultaneously, which may lead to greater fat-loss effects and improved metabolic control compared with current single- or dual-agonist drugs.


Price:
Price 1400.00 INR / Box
Minimum Order Quantity : 500 Boxes
Ingredients : OCTREOTIDE 50 MCG / 100 MCG INJECTION 1ML
Physical Form : Liquid
Quantity : 5 ampules of 1ml Boxes
Suitable For : Teenagers, Women, Adults, Aged Person
Price 1250.0 INR / Vial
Minimum Order Quantity : 500 Vials
Ingredients : Zoledronic Acid Infusion
Physical Form : Liquid
Quantity : 5mg vial Boxes
Suitable For : Adults
Price 30 INR / Vial
Minimum Order Quantity : 500 Vials
Ingredients : EMESET ONDASETRON
Physical Form : Liquid
Quantity : 2ml Pieces
Price 5700.0 INR / Box
Minimum Order Quantity : 5 Boxes
Ingredients : Synedica Retatrutide
Physical Form : Other
Quantity : 5 Boxes
Suitable For : Suitable For All